GlassScriptPhysician profile
Scott D Parrott
NPI 1114298908
$922.81
in general payments reported to CMS, 2019-2025
17 companies · $18.15 in 2025
The $18.15 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $360 · 2023: $336 · 2024: $74.94 · 2025: $18.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $183.92 | 2021-2024 | |
| Glaxosmithkline, LLC. | $132.94 | 2022-2025 | Trelegy Ellipta, Bexsero |
| Pfizer INC. | $109.71 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $87.79 | 2021-2023 | Breztri, Farxiga |
| Novo Nordisk INC | $66.02 | 2022-2023 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $65.80 | 2021-2023 | Vaxelis, Vaxneuvance, M-M-R II |
| Janssen Pharmaceuticals, INC | $45.87 | 2021 | |
| Dexcom, INC. | $37.41 | 2022-2023 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $33.25 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.07 | 2021 | |
| Sanofi-Aventis U.S. LLC | $24.61 | 2022 | |
| Daiichi Sankyo INC. | $20.89 | 2023 | Injectafer |
| Seqirus USA INC | $19.12 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.80 | 2022 | |
| Electromed, INC. | $16.91 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $15.35 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.35 | 2023 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Parrott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.